[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Social Media Role in Clinical Trial Recruitment Discussed in New Study Published at MarketPublishers.com

27 Jun 2012 • by Natalie Aster

LONDON – According to the researchers, engaging physicians in social media could be an effective way to recruit clinical trial participants. So far, firms such as Pfizer, AstraZeneca, Novartis, and Avanir, as well as governmental research entities and non-profit investigators have already turned to social media for help in recruiting.

However, this has been a particularly tricky development for the pharmaceutical industry, because while there are strict rules on just what a drug maker can say about its products, those rules have not been adapted by regulators to the new online environment.

New research study “Tapping Social Media for Clinical Trial Recruitment” elaborated by FirstWord has been recently published by Market Publishers Ltd.

Report Details:

Tapping Social Media for Clinical Trial Recruitment
Published: April, 2012
Pages: 69
Price: US$ 745,00

The research study offers a comprehensive guide to understanding why and how trial recruiters are using social media channels to reach target patients. Its scope comprises:

  • latest data and behavioural trends in social media usage; 
  • guidance on planning a social media presence; 
  • examples of how trial sponsors are already using social media recruiting; 
  • handy checklist of ways to engage your audience through social media; 
  • detailed advice on potential problems, including lack of regulations, privacy issues, and concerns about promotion of off-label indications; 
  • predictions for the next big developments in behaviour and attitudes; 
  • 4 pharma case studies – on using social media to find patients with a rare disease, and to recruit candidates for Phase II, Phase IIb and Phase III trials.

More new research studies by the publisher can be found at FirstWord page.


MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]

Analytics & News

Weekly Digest